Compare
5 stocks, side by sideRelative performance · rebased to 100
ARGXREGNALNYRVMDRPRX
| ARGXargenx SE | REGNRegeneron Pharmaceuticals | ALNYAlnylam Pharmaceuticals, Inc. | RVMDRevolution Medicines, Inc. | RPRXRoyalty Pharma plc | |
|---|---|---|---|---|---|
| Smart Score | 7/10 | 9/10 | 8/10 | 10/10 | 7/10 |
| Price | $888.65 | $623.43 | $293.17 | $178.17 | $54.69 |
| 1 month | +9.9% | -2.4% | -0.79% | +15% | +1.5% |
| 1 year | +56% | +22% | -9.8% | +345% | +55% |
| 5 year | +182% | +20% | +70% | +423% | +39% |
| P/E (TTM) | 37.1 | 14.7 | 67.8 | -27.6 | 29.3 |
| P/E vs sector | +18% | - | +115% | - | -7% |
| Market cap | $55.5B | $63.9B | $39.1B | $37.9B | $31.5B |
| Sector | Healthcare | Health Care | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.